Attention-deficit/hyperactivity disorder and substance abuse

Area of Science:

• Neurodevelopmental disorders
• Addiction medicine
• Psychopharmacology

Background:

• Attention-deficit/hyperactivity disorder (ADHD) is frequently comorbid with substance use disorders (SUDs).
• Children diagnosed with ADHD exhibit an elevated risk of developing SUDs compared to their non-ADHD peers.
• Stimulant medications, while effective for ADHD, carry potential for abuse and diversion.

Purpose of the Study:

• To outline practical strategies for minimizing SUD risk in ADHD patients.
• To provide guidance on the safe prescribing of stimulant medications for ADHD treatment.

Main Methods:

• This clinical report synthesizes current evidence and expert recommendations.
• Focuses on risk mitigation and safe prescribing practices for ADHD and SUD comorbidity.

Main Results:

• Identified key risk factors for SUD development in individuals with ADHD.
• Proposed evidence-based strategies for managing stimulant therapy.
• Highlighted the importance of careful patient selection and monitoring.

Conclusions:

• Integrated management of ADHD and SUD is crucial.
• Safe stimulant prescribing can reduce SUD risk in vulnerable populations.
• Ongoing research is needed to further refine treatment protocols.